enVVeno Medical Corporation (NVNO)
NVNO trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2019-12-31, https://www.sec.gov/Archives/edgar/data/1661053/000149315221007526/0001493152-21-007526-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2019-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | NVNO on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2018 |
| SEC CIK | 0001661053 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2019
| Line | Value |
|---|---|
| Revenue | $31K |
| Net income | -$7.6M |
| Operating income | -$7.7M |
| Net margin | -24406.7% |
| Operating margin | -24566.5% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $1.3M |
| Total assets | $3.4M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 132.2× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-10-29 |
| Cash and burn | $2.6M cash; operating cash flow -$3.4M a quarter. | Report 2026-09-30 |
| Shares outstanding | 694,826 (2026-10-27); 20,216,176 a year earlier; 13,317,000 three years earlier. 1y figure adjusted for splits (1-for-35 overall); 3y figure adjusted for splits (1-for-35 overall). | Cover page 2026-10-27 |
| Reverse splits, 3 years | 1; latest 1-for-35 on 2026-01-20 | Source 2026-01-20 |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 0 424B5 takedowns | Latest 2026-08-21 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | CBIZ CPAs P.C., New York, New York, United States; changed auditors 1 time in 24 months | 8-K 4.01 2025-04-21 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $5K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | Not filed | -$4.4M | -$3.2M | $2.6M | No debt tags | Needs four quarters | 10-Q 2026-10-29 |
| Q2 2026 2026-06-30 | Not filed | -$3.6M | -$3.5M | $2.8M | No debt tags | Needs four quarters | 10-Q 2026-07-30 |
| Q1 2026 2026-03-31 | Not filed | -$3.8M | -$3.2M | $2.6M | No debt tags | Needs four quarters | 10-Q 2026-05-06 |
| Q4 2025 2025-12-31 | Not filed | -$3.7M | -$3.4M | $3.1M | No debt tags | Needs four quarters | 10-K 2026-03-26 |
| Q3 2025 2025-09-30 | Not filed | -$4.5M | -$4.4M | $1.5M | No debt tags | Needs four quarters | 10-Q 2026-10-29 |
| Q2 2025 2025-06-30 | Not filed | -$6.7M | -$3.7M | $2.0M | No debt tags | Needs four quarters | 10-Q 2026-07-30 |
| Q1 2025 2025-03-31 | Not filed | -$4.5M | -$4.0M | $2.9M | No debt tags | Needs four quarters | 10-Q 2026-05-06 |
| Q4 2024 2024-12-31 | Not filed | -$6.2M | -$5.1M | $1.8M | No debt tags | Needs four quarters | 10-K 2026-03-26 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-08-21 |
| Latest annual report | 10-K | 2026-03-26 |
| Latest quarterly / interim | 10-Q | 2026-10-29 |
| Latest current report | 8-K | 2026-07-14 |
| Latest proxy | DEFA14A | 2026-10-29 |
Source: SEC EDGAR submissions feed, 416 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -8.3% |
| 1 month | -22.6% |
| 3 months | -43.2% |
| Year to date | -45.1% |
| 1 year | -73.0% |
| From 52-week high | -58.0% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SNOA | Sonoma Pharmaceuticals Inc. | $0.8802 | -19.25% | $4.5M |
| BDMD | Baird Medical Investment Holdings Ltd Ordinary Share | $0.1065 | +17.68% | $4.5M |
| ICU | SeaStar Medical Holding Corporation | $0.8535 | +1.80% | $4.5M |
| TNON | Tenon Medical Inc. | $1.33 | -5.32% | $3.6M |
| INBS | Intelligent Bio Solutions Inc. | $1.50 | -16.20% | $5.0M |
| XAIR | Beyond Air Inc. | $2.02 | -5.16% | $3.4M |
| WOK | WORK Medical Technology Group LTD | $1.23 | +2.50% | $5.5M |
| VVOS | Vivos Therapeutics Inc. | $0.0822 | -16.12% | $2.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier